𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low-dose recombinant interleukin-2 and low-dose cyclophosphamide in metastatic breast cancer

✍ Scribed by Darcy V. Spicer; Ann Kelley; Robin Herman; Grace Dean; Lucy Stevenson; Malcolm S. Mitchell

Publisher
Springer-Verlag
Year
1992
Tongue
English
Weight
331 KB
Volume
34
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

An effective low-dose intermittent cyclo
An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer
✍ Richard H. Creech; Robert B. Catalano; Michael J. Mastrangelo; Paul F. Engstrom πŸ“‚ Article πŸ“… 1975 πŸ› John Wiley and Sons 🌐 English βš– 571 KB

A low-dose, three-drug regimen, C.M.F. (cyclophosphamide 50 mg, P.o., days 1-14; methotrexate, 25 mg, and 5-fluorouracil, 500 mg, i.v., days 1 and 8; cycled every 28 days) was used in 46 consecutive chemotherapy-eligible women (41 previously hormonally treated) with recurrent breast cancer. Thirteen

High-dose versus low-dose CMFP regimen i
High-dose versus low-dose CMFP regimen in advanced breast cancer
✍ Anand Kumar; N. N. Khanna; C. C. Pant; S. Khanna πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 240 KB

Fifty cases of advanced breast cancer (stages III and IV) were treated by combination chemotherapy. The study compares the two different dose schedules and toxicities of a combination of cyclophosphamide, methotrexate, 5-flurouracil, and prednisone. Results are better with high-dose regimen, though